English

Transcription

English
The Israel-Europe
R&D Directorate
Bar Mitzvah - 13 years of success
Years of Israeli Association
in the European Framework Programme
for Research and Technological Development
A Salute to the Framework Programme
The Unique Contribution to Israeli R&D
A Bouquet of Israeli Success in the
Seventh Framework Programme
How to Participate in European Research Projects
Ministry of Industry,
Trade and Labor
Ministry of Science
and Technology
H A A R E T Z
Special Supplement
2
13
The Israel-Europe
R&D Directorate
2
Contents
3 FP7 Structure and Budget Overview
Bar Mitzvah - 13 years of success
Years of Israeli Association
in the European Framework Programme
for Research and Technological Development
A Salute to the Framework Programme
4 Greetings
6 Israeli Results in FP7
The Unique Contribution to Israeli R&D
A Bouquet of Israeli Success in the
Seventh Framework Programme
7 The Gateway to Europe
How to Participate in European Research Projects
Ministry of Industry,
Trade and Labor
Ministry of Science
and Technology
An Interview with Marcel Shaton, ISERD's General Manager
H A A R E T Z
Special Supplement
12 A Bouquet of Israeli Success
Stories of Israeli Success in the European Framework Programme
16 Winners Panel:
When Israeli Capabilities meet European Capabilities
19 How to Participate in European R&D Projects?
Ten recommendations
20 ISERD's Team
H A A R E T Z
Special Supplement
Editor: Joel Tsafrir | Production Manager: Smadar Averbuch | Graphic Design: Climax Studio www.climax-design.co.il
Advertising Manager: Haim Vienta Tel. 03-5121742 | Translation: Leehee Goldenberg
Commercial Manager: Hagit Levi | Print: Graphoprint Haaretz
Haaretz, Commercial Department, 21 Shoken St., Tel Aviv, Israel Tel:+972 3 5131311, Fax: +972 3 5121170
The publisher is not responsible to the content of the ads. The publisher wishes to clarify that the articles and/or the ads
aren't any recomandation of any sort.
3
13
Bar Mitzvah
3
Bar Mitzvah
Bar Mitzvah
Bar Mitzvah
The Seventh Framework Programme (FP7)
Structure & Budget Overview (in millions of euros)
Cooperation
32,463
Health
6,150
Food, Agriculture, Fisheries
and Biotechnology
1,935
Information and
9,050
Communication Technologies
Nanotechnologies, Materials,
Production
3,475
Energy
2,350
Environment
1,890
Initial Training Networks
People
(Marie Curie Actions)
Life Long Training and Career Development
4,750
Industry-Academia Path Ways & partnerships
International Dimension
Specific Actions
Capacities
4,097
Research infrastructures
1,715
Research for the benefit of
small and medium sized
enterprises (SME's)
1,336
Regions of knowledge
126
Research potential
340
Transport & Aeronautics
4,160
Socio-Economic Sciences &
Humanities
623
Space
1,430
Science in society
330
Security
1,400
Activities of international
co-operation (INCO)
180
Starting Independent Research Grants
IDEAS (European
Research Council-ERC)
Advanced Investigator Grant
7,510
Total FP7 Budget
Support for the coherent
70
development of research policies
48,820
Source: ISERD Database
From the award ceremonies honoring the winners in EU FP7 2007, 2008
4
13
4
Dear Readers,
Congratulations! Israel is marking its 13th year,
its "Bar Mitzvah" since having joined the European
Framework Programme. Throughout these years,
Israel has proved that its membership in the
Programme was not simply a political gesture, rather
a strategic long-term development, which has to
date significantly helped reinforce the research
and development ties between Israel and the
European community. In addition, it has fulfilled
Photo: Ofer Vaaknin
the expectations and interests of both sides, who
maintain a wide array of long-term close ties.
We are currently demarcating the halfway point of the Seventh Framework
Programme, which articulates a significant step-up in advancing R&D in
Europe. The sum allocated to support R&D in the current programme is
50 billion Euros spread across 7 years, of these, more that 32 billion Euros
have been allocated to support international cooperation in R&D. Like
its predecessors, the Seventh Programme grants a unique opportunity
to organizations and companies in Israel to form business and research
collaborations with leading organizations in Europe as well as provides
access for strategic integration in the research, development and marketing
frameworks of the continent.
Israel's full partnership in the Programme testifies to its leading role as
a scientific-technological player in the European forum as well as to the
achievements stemming from its participation in the previous Framework
Programmes. For example, in the Sixth Framework Programme, organizations
from Israel received research grants totaling 203 million Euros, making the
Programme a major source for R&D grants for Israeli companies, alongside
the grants from Israel's Chief Scientist. It is important to remember that the
financing options here are particularly attractive and the research's results
remain the company's property.
The European Framework Programme is currently marking 25 years
since its inception. Within this historical perspective one can say that it
has filled a unique and important position in Europe's integration and
the increased competitive capabilities of the European economy, all the
while strengthening the scientific-technological cooperation between the
continent's countries.
Regarding Israel, there is no doubt that the Programme, beyond representing
the faith given to Israeli industry and technology, has helped strengthen
Israel's integration into the European Research Area and has created the
support infrastructure and framework of activities which allowed it to find the
tremendous potential within the Framework regarding manpower, corporate
and business ties and commercial-industrial leveraging.
Israeli participation in the European R&D Programme has significant influence
on Israel's development and its status in the fields of science and technology.
Israel arrived at the Seventh Programme with significant experience from
the three previous Programmes. It is important to remember that Israel is
the only country outside of Europe that is an associated of the European
R&D programme. This on its own presents an ongoing challenge of making
itself as a significant player in the European scientific-technological arena.
The impressive achievements so far, stemming from the Israeli industry and
academia, testify to the manner in which the vision of participating in the
European Framework Programme has been visionary and has proved itself.
I truly believe that the European Framework Programme will continue
to represent an incentive to the realization of large projects, rich in vision
and financing, through exposure to new technologies and partnerships,
developing business relationships and penetrating into new markets. All
these elements are of significant importance to Israel and we must act to
preserve and strengthen them.
Sincerely yours,
Binyamin (Fuad) Ben-Eliezer
Minister of Industry, Trade and Labor
Focusing on leading infrastructure-strategic
research, bridging between basic research and
applied research, the Ministry of Science and
Technology sees the European Framework
programme as a very important leverage and as an
outstanding infrastructure for realizing this vision.
Israel is currently marking 13 years since joining the
European Program, an additional testimony to the
Photo: Avi Ohayun, La"m
success of the scientific-technological partnership
between Israel and Europe.
The European Framework Program is an additional important stage in the
national effort to advance and foster Israeli science. Regarding the market’s
globalization process, the development of science and technology must be
done in close cross-border cooperation with other scientific, industrial and
academic factors world wide, following a multi-disciplinary approach and in
the spirit of cooperation, with mutual flows of information and feedback. All
of these are expressed in the European Framework Program and provide
a small country like Israel with the ability to keep a high level of scientific
research, while expressly fostering a strong amount of scientific foreign ties.
The verity of this statement is strengthened and continues yearly, so long as
the trend of globalization of sciences continues to deepen.
In addition to the significant benefits Israel receives through its participation
in the Program, it is important to discuss a subject with significant national
importance, one that the Ministry of Science allocates significant research
to: the return of Israeli scientists. In this respect it should be noted, that the
European Framework Program granted dozens of scholarships to Israeli
researchers and scientists from industry and academia to fund their return
from the United States. In fact, Israel is in the top spot regarding scholarship
winner for the last call for proposals intended to return researchers to Europe,
and for this matter Israel is considered part of Europe.
During the internal discussion in Israel regarding Israel’s participation in the
Framework Programme, there were concerns that Israeli scientists would
not be able to enjoy these scholarships as they don’t actually express
Israeli-European collaboration per se. However, thanks to Israel’s actions
it was decided that these scholarships would also be available for Israeli
researchers returning to Israel from outside of Europe, based on the principal
that Israel should enjoy all the rights enjoyed by the Member States of the
European Union, which by means of this programme encourages European
researchers to return to their homelands.
As aforementioned, the main role of the Ministry of Science and Technology
is to preserve, foster and develop the existing knowledge base in Israel in
order to ensure the its future in the coming decades. The Ministry’s flagship
programme is the scientific infrastructures programme which encourages
inter-disciplinary, multi-disciplinary and inter-university research with
high levels of feasibility for industrial growth. This program represents a
bridge between basic academic research and industrial development and
minimizes the ripening period of useful technological ideas. In this regards
there is an important place for the integration of Israel into the European
Framework Programme.
Israel’s successful integration into the European Framework Program
is a remarkable achievement, intended for positive influence for the
advancement of science, the industrial ties with European States, for the
transfer of technology and Israel’s status as a leading scientific-technological
player in the international arena, particularly in the European arena.
I would like to bless all those who are involved, and wish us all that we will
succeed in going on making the best in the programme to leverage the
power of Israeli science.
Rabbi Professor Daniel Hershkowitz
Minister of Science and Technology
5
13
Bar Mitzvah
Bar Mitzvah
Greetings from the Commissioner for
Science and Research
At the end of 2006, I expressed my hope
in this publication that the positive past
experience would motivate Israel to further
boost the momentum for its participation
in FP7. Today, three years later and close to
middle of the lifetime of FP7, I am happy to say
that my hopes have been become reality!
Israel's success is continuing under FP7. This is remarkable since the
increase in the number of Member States and of Associated Countries,
as well as the general opening of the FP to international participation,
have led to much tougher competition for participation and funding.
The scientific excellence and flexibility of Israeli researchers and
enterprises have helped in adapting to these new conditions as well as
to the new instruments created under FP7. Thus, for example Israel's
participation in recent European Research Council calls, which fund
investor-driven frontier research, has been outstanding.
Beyond Israel's continued strong involvement in the Framework
Programmes one should not forget the other important elements
which mark the intensive Science and Technology (S&T) cooperation
between Israel and the EU: Israel is a full member of EUREKA and
since 2005, through Matimop, participates in the Galileo Joint
Undertaking, the European satellite navigation programme. Ten
EU Member States have concluded S&T cooperation agreements
or arrangements with Israel. Furthermore, Israel is, as an associated
country, actively involved in the further development of the European
Research Area. ERA is establishing a zone in which researchers,
scientific knowledge and technology can circulate freely.
I am confident that the EU-Israel S&T partnership will further contribute
to solving global challenges, such as climate change and dangerous
diseases, and that it will create links between people and thus be an
important building block for the further development of good overall
EU-Israel relationships.
Yours sincerely,
Janez Potocnik
European Commissioner for Science and Research
Bar Mitzvah
Bar Mitzvah
We are currently celebrating 13 years since Israel
joined the European Framework Programme. Although
compared to history this is a short period of time, we
can look back upon it with pride and satisfaction. The
participation of the Israeli academia in the programme
has proved itself to be a significant and prominent one
and has yielded substantial success rates. The analysis
of the results of the calls for proposals within the
currently ongoing Seventh Programme alone, shows
that the rate of winnings in the academic sector, stands
at more than 50% of the total wins. More than 30 young Israeli researchers
have won the programmes’ funds during the last two years and proved that
Israeli research and excellence have a bright future.
The Israeli academia is putting in significant, daily efforts to strengthen the
collaborations with industry, on both national and international levels. Despite
that fact that most of its role is basic research, according to the researcher’s
will, which stems from the academic freedom the Israeli academia is blessed
with, every fitting academic institution has a commercializing company
whose role is to identify, locate and leverage the relevant basic research
with the aim of realizing it into a commercial and industrial products. In this
sense, there is significant importance in the Israeli academia’s participation
in the European Framework Programme as an additional channel to transfer
technology and leverage the knowledge collected within the walls of the
academia, all the while translating it into realizable projects.
The European Union decided to place Europe in a leading position in
scientific research. In this regard it is important to note that the Seventh
Framework Programme established the European Research Council (ERC)
through which it runs a competition regarding excellence in technological
innovation on a European level. Here, grants are awarded to ground breaking
researchers. So far 58 Israeli researchers have been awarded these grants,
totaling over 70 million Euros. These wins place Israel in the leading position
in Europe relative to the number of researchers in the country. In addition,
within “People” programme the ‘International Reintegration Grant’ enables
Israel to reabsorb Israeli researchers working in the United States and to
integrate them into the academic research in Israel.
The participation of the Israeli academic institutions in the Framework
Programme, since the Fourth Programme, has not always been easy and
was accompanied by a number of obstacles. However, over time and with a
constant learning process, Israel’s status improved and the Israeli academia
succeeded in leveraging Israeli participation in the European Programme
and to maximize its yield.
Participation in a multi-national European programmes enables scientists
and researchers access to large research facilities, along with their integration
into large international scientific partnerships which are not always readily
available under normal conditions. This provides Israeli institutions of higher
education the opportunity to express their abilities and to realize their
potential for the benefit of society and the economy.
Much has been said about the return on the Israeli investment in the
European Framework Programme. In the beginning doubts were still voiced
regarding the return Israel was getting for the funds it contributed to the
Programme. It seems to me that today no one doubts that Israel has indeed
returned its investment and with significant yield. For the Israeli academia,
this means direct research grants for Israeli scientists and scientifictechnological-industrial partnerships at monetary scopes which exceed by
far the original investment.
Israeli sciences in general and particularly Israeli scientists are highly esteemed
around the world. The Nobel Prizes Israeli scientists have been awarded
in recent years bear witness to this. We must continue to invest in the
development of the basic and applied research in Israel to ensure the might
and power of Israeli society despite the challenges of the 21st century. The
Israeli participation in the European Framework Programme is a significant
factor in the achievement of this goal and we should put in national efforts to
ensure the continuation of this praiseworthy partnership and intensify it.
Sincerely,
Professor Manuel Trachtenberg
Chairman of the Council for Planning and Budgeting,
the Council for Higher Education
5
6
13
In honor of the "Bar Mitzvah" of Israel's joining
the European R&D Programme, it is important to
highlight the significance of its participation in these
programmes.
The scope of the investment in civilian R&D as a
measure of Israel's outcome stands at 4.5%, a figure
which places Israel at the global top in the field of
research and development. Israel is also a leader
Photo: Ofer Vaaknin
regarding the scope of technological manpower, in
addition, in the field of patents, Israel has substantial
achievements, while being a global leader for the rate of patents in the field of
medical equipment and has positioned itself in fifth place in the rate of patents
per person.
These are but a few examples of a variety of impressive data, particularly
for a small country, numbers to be proud of. But we shouldn't rest on our
laurels. We live in a dynamic global reality, the competition is fierce and many
countries are catching up and quickly. A prominent example is South Korea
that has leapt forward in the last decade.
It is important to note that Israel's main asset – its manpower – necessitates
non-stop investment and care. This is a critical investment for our future
as a society and a country. Israel already possesses the infrastructure and
potential to improve its economic situation and its global positioning.
To succeed, it is necessary to increase the investment in science and
technology. These investments represent a fantastic driving force for growth,
and are necessary particularly due to the global recovery and the increased
competitiveness.
The European Framework Programme, which we are currently celebrating
13 years of Israeli association, has represented throughout these years a
remarkably important means for the advancement of collaboration in the
field of R&D between industrial companies and academic institutions in
Israel and their colleagues in Europe. The latter enabled Israeli companies
from all fields and of all levels – from startups to large corporations – to
develop, expand their knowledge, their abilities and capital as well as assist in
their development, as part of the impressive expansion in the Israeli market
over the last decade. For the academia, the Programme offers a significant
platform for development and scientific excellence.
The Seventh Programme (FP7) is larger and more ambitious than its
predecessors. In fact, this programme as well as other programmes which were
developed within the European Union, are leading a significant step whose
purpose is doubling the European investment in research and development.
The Seventh Programme, which will continue until 2013, deals with, amongst
others, the fields of communication, nanotechnology, biotechnology, software,
agriculture, energy, space and security. Israel's industries and research
institutions have a significant competitive advantage in all of these fields. The
collaboration with the academia and corporations in Europe are likely to assist
in the advancement of Israel's abilities in these fields.
Being part of the programme allows the Israeli academia and industry to
integrate into the most advanced R&D programmes in the world, to be
exposed to knowledge that is pertinent for the advancement of science and
industry and to be positioned at the forefront of global technology. Thanks to
the ties and collaboration in R&D created through the Programme's activities,
new markets have opened up for Israeli companies' products and significant
business opportunities have been created. In addition, participation in
the Framework Programme strengthens the industrial and academic ties
with Europe, while providing access to large research budgets, innovative
knowledge and business intelligence. Currently the Seventh Programme is a
significant source of funding for many researchers in the Israeli academia.
It is worth mentioning that the benefit to the State of Israel is not measured
solely through direct financial return, rather through the participation of
the Israeli R&D community in research whose scope is billions of Euros.
The research and development, the information and knowledge that Israeli
researchers are exposed to, along with the ties built with the European
Union and the industrialized countries within it, create an important strategic
partnership for Israel.
Dr. Eli Opper
Chief Scientist
Ministry of Industry, Trade and Labor
Chairman of ISERD's Steering Committee
Israel's Results in FP7 - November 2009
Israel's contribution to FP7 so far: 160 M€
Submitted Participations
3446
Successful Participations
698
Success by sector:
Industry
152
University
426
Others
120
Submitted Proposals
2446
Successful Proposals
247
Success Rate
Value of Israeli grants: 243 M€
20.3%
Industry
71 M€
University
154 M€
Others
18 M€
Overall value of projects with at least one Israeli partner
3.4 B€
Overall value of projects with at least one Israeli Industrial partner
1.3 B€
Source: ISERD Database
6
Bar Mitzvah
Bar Mitzvah
The Gateway
to Europe
Joel Tsafrir
"Participating in the European Framework
Programme grants Israeli companies access to
knowledge and information that leverages the value
of the project and the scope of the exposure", says
Marcel Shaton, General Manager of ISERD, the
Israel-Europe R&D Directorate, that promotes the
participation of Israeli entities in projects within the
European Framework Programme
In the Jewish tradition, age 13 demarcates
the Bar Mitzvah ceremony. If you like, it is a
Jewish membership ceremony. Differentiating
between childhood and maturity, and expresses
the transformation of a child into an adult from a
Jewish Law point of view, something which allows
and even obligates him to perform the entire
commandment (Mitzvahs). Why are we reminded
of this? Because Israel is currently celebrating 13
years since it joined the European Framework
Programme, whose goal was to promote
cooperation in the field of research & development
between the continent's countries. In a number
of aspects this milestone is also a symbolic one,
since after a modest and hesitant beginning, which
has become a strategic project for Israel, when
academic institutions and business companies
found a uniquely important channel for crossborder cooperation, funding, investments and the
advancement of financial initiatives and projects
on growing scales. For the Israeli academia, for
example, the Programme has become a source
of funding comparative in size with the research
budget of the National Science Fund.
Israel joined the European Framework
Programme in 1996. It is important to note that
those days were the post-Oslo days of euphoria,
when as gesture of goodwill and as recognition
of its scientific status Israel was added to the
Framework Programme with the status, of
associated country. Israel began participating in
the Programme, in practice, during the Fourth
Framework Programme. Despite being defined
as an accompanying partner, Israel enjoys all the
rights of a member state and it is actually the only
sphere in Europe where Israel enjoys all the rights
provided to the Member States of the European
Union.
What began as a political gesture quickly
became clear to both parties as a worthwhile
transaction. Israel, thanks to the large investment
in civil R&D and with excellent manpower in the
fields of engineering, biotechnology and HiTech, was quickly seen as worthy member and
wanted partner in the Programme. On their part,
the Israelis throughout the years, got to know the
Programme's advantages, and all its layers. It's true
that the Programme necessitates the direct flow of
Photo: Ziv Sade
13
Bar Mitzvah
Bar Mitzvah
the extent of 167 million Euros. Therefore, the
debate regarding the Sixth Programme was much
simpler. Israel transferred over 191 million Euros
and received 204 million Euros. In the current
Programme – the seventh, so far Israel has
transferred 160 million Euros and has received
243 million Euros. The total payment that Israel
"For Israeli companies the R&D is a huge opportunity to acquire
knowledge and create long term ties and not just a channel for
funding in the short term. This is due to the fact that the research
takes place in close cooperation with a number of factors"
government funding to the shared coffer, but the
return received at the end of the day is bigger and
more significant.
At the beginning, Israel transferred over 100
million Euros to the Programme and received only
50 million Euros in return, something which led a
number of public bodies in Israel to fear that there
was no financial feasibility in the Programme. As
time passed, the balance sheet changed. During
the Fifth Programme, Israel transferred over 154
million Euros and received research funding to
will transfer to the Framework Programme by
2013 is estimated at half a billion Euros.
"Despite the financial data which is attractive
on its own, the quantitative aspect is not
everything," claims Marcel Shaton, the General
Manager of ISERD, the Israeli Diractorate for the
European Framework Programme for Research
and Development, which is responsible for the
implementation of the Programme in Israel.
"For Israeli companies the participation in
7
8
13
the Framework Programme opens a range of
opportunities to acquire knowledge and create
long term ties and not just a channel for funding
in the short term. This is due to the fact that the
research takes place in close cooperation with a
number of factors. Most of the companies enjoy
a flow of knowledge which goes beyond the
cash flow in importance. So far, in the Seventh
Programme, the projects with at least one Israeli
industrial company's participation are valued
at 1.3 billion Euros. According to conservative
estimations at least one third of this sum is the
value of the knowledge utilized by the Israeli
industry.
"Take Peptor for example – an Israeli
biotechnology company, not too big, which develops
a certain molecule. Peptor, and this is a real story
from the field, only received 30,000 Euros in funding,
but actually saved 1.8 million Euros in clinical
research which it intended to carry out anyway. In
addition, try to imagine the amount of knowledge,
connections and reputation it accumulated from its
participation in the Programme. The Israeli Company
Compugen was the coordinator of a consortium
which built gene data banks, which had it wanted to
establish alone would have had to fund it by itself.
Therefore the company saved impressive budgets
and resources. It is important to think in these
terms and not in terms of cash flow alone. This is a
powerful leverage."
Science and Industry Ties
Israel's acceptance as an associated member
into the European Framework Programme is still
considered to be one of Israeli diplomacy's biggest
achievements. After all, Israel is the only country,
other than Switzerland, which isn’t a member
state or candidate country of the European Union,
which has earned this status. This has significant
value for Israeli science and technology which
influences on science itself, on industry ties with
Europe, including technology transfer, regarding
the enhancing of Israel's international status as
well as attracting R&D investments to Israel. Israel
is becoming attractive to foreign investments in
the field of R&D as the R&D units found in Israel
qualify for European funding from the Framework
Programme. This explains the widespread activities
of companies such as IBM, Microsoft, SAP's first
steps and Intel's new initiatives.
To translate the success of diplomacy into
practice ISERD was founded – the Israeli
Directorate for the European Union Framework
Programme for Research and Development.
ISERD's actions are led by an inter-ministerial
steering committee headed by the Chief Scientist
of the Ministry of Industry, Trade and Labor, Dr.
8
Eli Opper, and whose partners are the
Ministry of Industry, Trade and Labor,
the Ministry of Science and Technology,
the Foreign Ministry and the Ministry of
Finance, as well as a representative of the
Planning and Budgeting Committee of the
Council for Higher Education, responsible
for academic research funding through the
National Science Fund. ISERD's General
Manager, Marcel Shaton, is the spirit
behind the programme in Israel. Shaton,
a former Minister for Economic Affairs in
Brussels, has been active for many years
in the Ministry of Industry, Trade and Labor
as well as in the field of foreign trade. As
someone who came from the hallways of
the EU in Brussels, he is considered to be
one of the most important and prominent
experts in the field of commercial and
diplomatic ties with Europe.
What is ISERD's main mission in your
opinion?
"Our mission is twofold: to strengthen
Israel's integration into the European
research area and to create a support
infrastructure and an array of activities
to take full advantage of the European
R&D Programmes. If you will, we are
ambassadors of the Israeli industry and
"We work both to advance Israel's matters with the European
Commission, and we make sure the funding programmes and the
projects will match Israel's case, as well as serve as liaison officers
in all the sub-programmes of the Seventh Programme"
academia in the European Commission and
ambassadors of the European Union amidst these
factors here. We work both to advance Israel's
matters with the European Commission, we make
sure the funding programmes and the projects
will match Israel's case as well as serve as liaison
officers in all the sub-programmes of the Seventh
Programme".
What are the benefits to Israeli factors
considering joining the Programme?
"There is a wide variety of benefits, and it is
my opinion that the most important one is the
access to the European market. I like to call it the
"gateway to Europe", or the "highway to Europe."
We're talking about a huge market of knowledge,
services, capital and budgets, as well as a huge
human expanse with 500 million residents, and
a number of new markets with its borders. In my
opinion, this is an important component in the age
of globalized markets. We are geographically and
culturally close to Europe and we should be taking
advantage of this as much as possible. Within
the Framework Programme, unique tools are
provided to realize the potential of this proximity.
The proximity to Europe allows us as Israelis
to learn as well as understand the ways things
are run and the European way of thinking which
is a pertinent component in today's business
world. The acquaintance with clients, suppliers
and competitors, across the continent, provides
the factors in Israel with business intelligence
in an exceptional quantity and quality, through
widespread exposure, particularly partnerships for
innovative technologies, as well as involvement
in the design of new standards, which possess
9
13
Bar Mitzvah
deep financial significance. Getting to know
and understanding the industrial, technological
and social processes has added value which
is no less important that the direct economic
benefit. The ability to be a part of a pan-European
network also has considerable value, particularly
for a small country. Meaning, the ability to enjoy
participation in large projects, rich in vision, all the
while being granted financial grants without having
to relinquish any intellectual property. In short,
this is a significant leveraging opportunity for the
Israeli companies and academia. I see significant
importance in cooperating with the Israeli industry
and academia as well as the entire local R&D
community in the European Research Area, which
provides the opportunity to break out of the local
market and into a large global powerful multidimensional market."
What does the Seventh Programme focuses on?
"The Programme's structure includes four main
fields: Cooperation, between different research
organizations in different countries with the aim
of achieving a leading position in a scientific or
technological field. We're talking about fields such
as health, agriculture, energy, communications,
environment, transportation, space, security
and more. This field makes up 64% of the
Programme's budget. An additional field: Ideas,
whose goal is to encourage and support new ideas
and basic research in all fields, it makes up 15%
of the budget. In the field of People the intention
is to strengthen the human capital in the fields of
research and technology, including training, career
development, strengthening science-industry
ties and more. This field makes up 11% of the
budget. And the final field: Capacities which deals
with research infrastructure, research for small
and medium size enterprises (SME's), science in
society, international cooperation and more, with
8% of the budget allocated."
Are there specific fields which may be of
particular interest to Israelis?
"In my opinion, Israeli companies and academia
may find a significant interest in most of the fields.
The numerous and various fields include health,
with an emphasis on biotechnology, food and
agriculture, information and communications, nanotechnology, energy, with an emphasis on alternative
and renewable energy, the environment, space and
security. Israel is considered a prominent player who
holds an advantage position in all these fields in the
international arena and is likely to enjoy research
grants and participation in consortiums which will
clarify Israel's relative advantage in the European
market."
Bar Mitzvah
Bar Mitzvah
Bar Mitzvah
Which figures regarding the Israeli participation
in the Seventh Programme can you present
already?
"By analyzing the calls for proposals in the
Seventh Programme from the start and up until
November 2009, it seems that the number of
participants stands at 3,446 and the number of
successes at 698. An analysis of the success rate
by sectors shows that the industry registered 152
successes, 426 successes for the universities
and 120 for other factors, meaning a 20%
success rate. Regarding research grants, Israeli
organizations received 243 million Euros of which
the industry received 71, the academia 154 and
other organizations received 18 million Euros. It is
important to mention that regarding industry, added
onto this is the value of knowledge made available
which is measured to be at least 400 million Euro.
The Programme emphasizes large projects. Do
the latter prevent the participation of small and
medium size enterprises?
"Definitely not. We are talking about large-scale
projects, but the consortiums' are composed
of numerous actors, part of which are likely to
be small and medium size enterprises. Actually,
Europe encourages this. We too, here in Israel,
have established a support fund for small and
medium sized enterprises which helps these
companies submit proposals to the Seventh
Framework Programme. The goal is to encourage
small and medium sized enterprises to participate
in the calls for proposals, through funding
assistance, in the search for other partners in
Europe and for tie-building with them."
Strengthening of European Integration
"The main goal of the European Framework
Programme was to strengthen the European
integration process" says Marcel Shaton, ISERD's
General Manager. "You can call it an additional
tool in the pan-European effort to overcome the
national instinct in exchange for the European
entity, with the aim of advancing cross-border
cooperation between scientists, researchers
and academics from different countries, as a
way to advance economic and social projects.
The idea is to create a mechanism which will
represent a framework which promotes the
existence of joint projects between Germans, the
French, Swedes, Italians and so on. The process
is carried out through the publication of calls
for proposals in the different fields of R&D and
creating joint consortiums with the participation of
entrepreneurs, researchers, people from industry
and academia, as well as different organizations
from different nationalities and countries. The
multi-player consortium is a central tool which
translates the idea of cooperation into practice,
incorporating within it factors from a number of
countries and sectors within the countries."
At the beginning, Shaton explains, the Programme
was run according to cooperation lines similar to
those customary in the academia, but over time
a correct and desirable balance was achieved on
the academia-industry axis and the Programme
became one of the most important factor in the
European economy which connects between two
interfaces. The Programme also moved from a
four-year budget to a seven-year budget, which
increased the ability to plan in the long term as
well as the budgets and resources which were
made available to the Programme. If between
1984 and 1987 the Framework Programme's
budget stood at 3.3 billion Euros, today the
budget for 2007-1013 stands at no less than 49
billion Euros. In recent years, the growth stems
from other states joining the Programme due to
the expansion of the European Union. In general,
the Seventh Programme has set the bar higher in
all aspects and is considered not just the longest
and most expensive, but rather also the most
ambitious Programme of all its predecessors. The
Seventh Programme also launched a new panEuropean competition designated for individual
researchers to fund groundbreaking research
and by this create the "European Nobel Prize
Winners Reserves". Israel particularly excels in this
programme with 58 wins totaling over 80 million
Euros.
In addition to the political goal of advancing
European integration, the Programme's designers
saw additional goals, such as the increase in
capacity for competitiveness of the European
economy, particularly vis-a-vis the creation of large
trade blocs in the world and the rise of economic
superpowers such as China and India, job creation
and improvements in quality of life, while solving
problems with economic and social significance.
The Seventh Framework Programme includes
27 member states and an additional 11 states
that are not members but that are in some sort
of proximity to Europe. This is part of the process
of getting closer and good neighbors' attitude
defined as one of Europe central goals in the era
of globalization and inter-bloc competition on the
economic level.
9
*4&3%
Your
Port
To FP7
In
ISRAEL
FP7 is
r
o
f
e
l
The ru ELLENCE
EXC
for a
g
n
i
k
Loo TNER?
PAR
ne in
o
d
n
i
F
L
ISRAE
Winners from the Israeli Industry
Acktar Ltd.
Afcon Software and Electronics Ltd.
Algatechnologies (1998) Ltd.
Alpha Omega Engineering Ltd.
Alvarion Ltd. - coordinator
Applied Spectral Imaging Ltd.
Argad Ltd.
BandWD Ltd.
Baruty & Sons Ltd.
Better place
Browzwear international Ltd. (Israel)
Correlation Systems Ltd.
Elbit Systems Ltd. – 3 projects
Environmental & Water Resources Engineering
Exent Technologies Ltd. - coordinator
FamCorner Ltd. - 2 projects
Freshpoint Ltd.
Hanita Coatings Ltd.
IBM Israel Ltd. – coordinator, 8 projects
Idea Bio-Medical Ltd. - 2 projects
ImageSat Israel Ltd.
Intel Electronics Ltd.
Israel Aerospace Industries Ltd. – 5 projects
Israel Airports Authority
Israel Electric Corporation Ltd. - 3 projects
Kaltura, Inc.
Lapidoth Israel Oil Prospectors Corp. Ltd.
LiveU Ltd.
MedInvest Holding
Microsoft Israel R&D (2002) Ltd.
Motorola Israel Ltd. - 2 projects
NanoMaterials Ltd. Israel
Nevet
Nicast Ltd. - coordinator
Optibase Ltd. - 3 projects
Orbotech Ltd.
Orckit-Corrigent Ltd - coordinator Ltd. - coordinator
Ortholine Ltd.
Prochon Biotech Ltd.
Dr. Raz Zarivach
Interdisciplinary Center (IDC) Herzliya
Dr. Doron Friedman
Dr. Sarit Markovich
Ort Braude College of Engineering
Dr. Judith Abrahami
Technion - Israel Institute of Technology
Prof. Hagit Attiya
Prof. Gad Bahir
Dr. Ayelet Baram-Tsabari
Prof. Jacob Bear
Dr. Eli Ben-Sasson
Dr. Sonia Berrih Aknin
Dr. Zeev Bomzon
Dr. Eyal Buks
Dr. Yacov Crammer
Mr. Mark Davison
Dr. David Gershoni
Prof. Boaz Golani
Prof. Shalom Hakkert
Prof. Amnon Harel
Prof. Yael Herer
Dr. Ehud Keinan
Dr. Kinneret Keren
Dr. Estee Kurant
Dr. Shulamit Levenberg
Prof. Efrat Lifshitz - 2 projects
Dr. Shie Manor
Prof. Avi Marmur
Prof. Ariel Miller
Prof. Uriel Orda
Prof. Miriam Reiner
Prof. Uriel G. Rothblum
Dr. Sigal Savaldi-Goldstein
Prof. Assaf Schucter
Prof. Mordechai Segev
Prof. Dov Sherman
Dr. Ariel Stanhill
Prof. Yeshayahu Talmon
Prof. Nir Tessler Born
Dr. Itay Fischhendler - 2 projects
Dr. Igal Galili
Dr. Nir Halman
Prof. Sergiu Hart
Prof. Joseph Hirschberg
Dr. Adi Inbal
Dr. Sebastian Kadener
Prof. David Kazhdan
Prof. Bianca Kühnel
Prof. Alexander Levitzki
Prof. Aaron Lewis
Prof. Shlomo Magdassi
Dr. Eran Meshorer
Dr. Yaakov Nahmias - 2 projects
Prof. Eran Razin
Prof. Aner Shalev
Dr. Eran Sharon
Prof. Roy Shinar
Dr. Jake Solomon
Dr. Daniel Strasser
Prof. Albert Taraboulos
Dr. Edit Tshuva Goldberg
Prof. Itamar Willner
The Open University of Israel
Prof. Miriam Souroujon
University of Haifa
Dr. Ayelet Ben-Sasson
Dr. Amit Bernstein
Dr. Anat Prior Unger
Prof. Kobi Rosenblum
Weizmann Institute of Science
Prof. Uri Alon
Prof. David Cahen
Prof. Milstein David
Dr. Barak Dayan
Prof. Irit Dinur
Dr. Michael Epstein
Prof. Zelig Eshhar
Prof. Tamar Flash
Prof. Lucio Frydman
ISERD’s Steering Committee
Chaired by Dr. Eli Opper Chief Scientist of the Israeli Ministry of Industry, Trade and Labor
Marcel Shaton, General Manager of ISERD
and ISERD’s Team
Congratulate the 258 outstanding companies and researchers for their winning of EU FP7
research grants in the passing year:
The Israel-Europe
R&D Directorate
For EU FP
Council for Higher
Education
Planning&Budgeting
Committee
Ministry of Science &
Technology
‫ת‬
Office of the Chief Scientist
Ministry of Industry
Trade & Labor
03-5118122
Registration at:
)PMETXFFLMZ
0SJFOUBUJPO
1SFTFOUBUJPOT
PO&6'1
www.iserd.org.il
Dr. Itai Yanai
Dr. Dvir Yelin
Dr. Shaked Yuval
Dr. Lihi Zelnik-Manor
Prof. Noam Ziv
Prof. Yoram Zvirin
Tel Aviv University
Prof. Niv Ahituv
Prof. Eddie Aronovich
Dr. Yaniv Assaf - coordinator
Prof. Eyal Ben-Dor
Dr. Michael Birnhak - ICTAF
Prof. Reuven Boxman
Dr. Haim Diamant
Prof. Tommy Dreyfus
Dr. Micha Fridman
Prof. Menachem Goren
Prof. Dagan Hanoch
Dr. Tali Hatuka
Dr. Anat Hershkovits
Dr. Oded Hod
Dr. Tali Kaufman
Dr. Boaz Klartbag
Prof. Michael Kozlov
Prof. Abraham Kribus
Prof. Yishay Mansour
Dr. Uri Nevo
Prof. Abraham Nitzan
Dr. Itzhak Omer
Dr. Dan Peer
Dr. Yael Roichman
Prof. Michael Romann
Dr. Alon Savidor
Dr. Hila Shamir
Dr. Yair Sharan - coordinator - ICTAF 2 projects
Dr. Carmit Tadmor
Prof. Hezy Yeshurun
The Inter-University Computation Center – IUCC - “MACHBA“
Mr. Moshe Gottlieb
Dr. Henry Nussbacher
The Hebrew University of Jerusalem
Dr. Knafo Ariel
Prof. Yechezkel Barenholz
Prof. Shimshon Belkin
Dr. Noam Berger
Dr. Liram Carmel
Dr. Ehud Cohen
Dr. Yuval Dor
Dr. Shabtay Dover
Dr. Leor Eshed Williams
Mrs. Pnina Feldman
Dr. Daniel Felsenstein
Winners from other Sectors
Agricultural Research Organization (Volcani) - 2 projects
ARTTIC Israel - Halevi Dweck & co. - 2 projects
Association for Medicine and Research in Galilee
Beacon Tech Ltd. - 2 projects
Bloomfield Science Museum - 2 projects
Clalit Health Services
Edna Pasher, Phd.&Associates - coordinator
Ernst &Young-Israel
Euro-Consultants Ltd.
Geological survey of Israel
Geophysical Institute of Israel
Hadassah Medical Organization - 2 projects
Intergam Communications Ltd.
Israel Antiquities Authority
Israel Association of Electronics & Software Industries
Israel Oceanographic & Limnological Research Ltd. (IOLR) - 2 projects
Maccabi Healthcare Services - 2 projects
Mada Tech- Israel National Museum of Science, Technology & Space
MAKASH - Advancing CMC Applications in Education, Culture and Science
Migal-Galilee Technology Center- coordinator, 2 projects
Ministry of Agriculture and Rural Development - 2 projects
Ministry of Science, Culture and Sport
Or Yarok
Osm-Dan Ltd. - 2 projects
Tel-Aviv Sourasky Medical Center - 2 projects
The Chaim Sheba Medical Center - 3 projects
The International Security and Counter - Terrorism Academy - ISCA
Prof. Yuval Gefen
Prof. Benny Geiger - 3 projects
Dr. Lilach Gilboa
Dr. Shahal Ilani
Prof. Klein Jacob
Dr. Tali Kimchi
Dr. Rafal Klajn
Prof. Doron Lancet - 2 projects
Dr. Sharon Michal
Prof. David Milstein
Dr. Elchanan Mossel
Prof. Nir Orion
Dr. Zvi Paltiel
Dr. Rony Paz
Dr. Gilad Perez
Prof. Uri Pick
Prof. Itamar Procaccia
Prof. Omri Moshe Sari g
Dr. Oren Schuldiner
Dr. Maya Schuldiner
Prof. Michal Schwartz
Prof. Reshef Tenne
Dr. Assaf Vardi
Industry House, 29 Hamered St. Tel-Aviv
Tel: +972-3-5118118 Fax: +972-3 -5170020 [email protected]
Winners from the Israeli Academia
Academic College of Tel Aviv - Jaffa
Dr. Merav Zion-Cohen
Bar Ilan University
Dr. Michal Ben-Shachar
Dr. Ofer Bergman
Dr. Miriam Bitton
Dr. Haim Cohen
Mrs. Shoshana De la Fuente
Dr. Sol Efroni
Dr. Maoz Fine
Prof. Aharon Gedanken - coordinator, 2 projects
Prof. Joseph Glicksohn
Dr. Miri Goldin
Dr. Yehuda Lindell
Dr. Israel Isser Peer
Dr. Avi Peer
Prof. Jonathan Rabinovich - coordinator
Dr. Sven Ruhle
Dr. Orit Shefi
Dr. Shlomo Shpiro - coordinator
Ben-Gurion University of the Negev
Prof. Miriam Amit
Prof. Sammi Boussiba , 2 projects
Dr. Ron Dabora
Dr. Opher Donchin
Prof. Yael Edan, 2 projects
Prof. Moshe Gottlieb
Prof. Moti Herskowitz
Dr. Robert Marks
Dr. Ohad Medalia
Dr. Michael Meijler
Dr. Haim Permuter
Dr. Oren Rigbi
Dr. Maoz Shamir
Dr. Ilya Tyomkin
Procore Ltd.
Pronto Diagnostics Ltd.
Protein Production Services Ltd.
RAD Data Communications Ltd.
Rafael Advanced Defense Systems Ltd. - 2 projects
Raicol Crystals Ltd.
Rotem Industries Ltd.
Saliwell Ltd. - 2 projects
SAP Israel
Siemens PLM Software Ltd.
Siklu Communications Ltd.
Teva Pharmaceutical Industries Ltd.
Verint Systems Ltd. - coordinator - 2 projects
Yitran Communications Ltd.
Yodfat Engineers (1994) Ltd.
12
12
13
A Bouquet of Israeli Success
Joel Tsafrir
Designing Europe's future communications network architecture, managing large-scale
disasters, developing target oriented medicines for cancer, minimal-invasive surgeries
using robots, rehabilitation of ground water, genetic enhancement to increase crops and
teaching nanotechnology to youth – these are but a few of the European projects Israeli
industrial companies, universities and other organizations have participated in as part of
the Seventh Framework Programme for Research and Development. Here we present
a selection of projects with Israeli participants who have been granted funding which
represent the competitive advantage of the Israeli R&D
Designing Europe's Future Communication Network
A Support System for Decision-Makers in Emergencies
ETNA Project
ESS Project
Israeli partners: Nokia Simmons Israel – Coordinator; Ethos Networks;
Ben-Gurion University in the Negev; Ernst & Young Israel
Prominent partner: British Telecom; Nokia Simmons, Germany
Budget: 3.4 million Euros
ETNA is a key project for developing efficient architecture for the internal
European Network. This architecture will be able to serve millions of
subscribers, with high and credible transport quality while supplying different
network services, some of which are already in use today, while others are
planned to be developed in the future. The successful construction of these
architecture networks such as this will help the future design of knowledge
and communication technologies and will provide a variety of new
opportunities for the creation of value added products and services. One of
the project's goals is to find a solution wherein infrastructure providers will be
able to supply services at a wide geographical range, through coordination
and connectivity between the cross-border communication services in
Europe.
Israeli partners: Verint Israel; Aeronautics; Magen David Adom Israel;
Ernst & Young Israel
Prominent partner: Alcatel-Lucent Italia
Budget: 14.5 million Euros
The Emergency Support System (ESS) project's core combines the
application and use of information technologies in real-time and it's
meant to provide information to decision-makers to allow for the educated
management of crises and irregular events such as stadium evacuation,
forest fires, leakage from nuclear reactors, accidents at toxic waste dumps
and others. Decision-makers are often required to make decisions in a
short period of time and information from the field is critical. Using a lifesaving system to manage and control the event, through the real-time
synchronization of ground forces (police, rescues and firefighters) and from
scene supervision and control centers. The approach guiding the project is
based on channeling the details received from the field to the central system
which will provide the information analysis and support applications in the
decision-making process. The project strives to improve data assembly
technology (radioactive, biochemical, audio-video and so on) to be installed
on mobile and fixed platforms, and will supply flexible, yet complete,
coverage of the contaminated area while reducing the uncertainty which
characterizes emergencies.
Health Risk Prediction & Management
GAP Project
Israeli partners: The Israeli Ministry of Health; Macabbi Health Services
Prominent partners: The Spanish Ministry of Health; The National
Institute for Health Research, France
Budget: 1.3 million Euros
Swine Flu, which is currently sweeping through the world, is an example
of the need to manage health crises which are today befalling the global
arena. These crises necessitate advanced organization, danger identification
and preparing the plans and the tools needed for government and intergovernment intervention at times of crisis. This project tests the entire
spectrum of calculating, preparation and managing risks in the field of health,
while creating the tools which will allow for intervention in real-time crises.
The project will evaluate all of the contemporary and future solutions for
health crises, with the aim of assisting decision-makers in managing them
while being provided with assistance from computerized tools to gather
and broadcast information. . The challenge is to construct a genuine system
to manage health crises and social protection and its components on a
European and global level.
Designing the First Responder Reaction to Large-Scale
Disasters
NMFRDisaster Project
Israeli partner: Magen David Adom
Prominent partners: Ambulance Services, Holland; Red Cross of Spain
and Denmark; The Centre for Science, Society and Citizenship, Italy; AlQuds University, West Bank (and Gaza strip)
Budget: 815,000 Euros
Identifying the Needs of Medical First Responder in Disasters
(NMFRDisaster) is critical. It requires the immediate reaction of a skilled
team, this project intends to examine needs of the medical first responders
in disasters, such as those of emergency and rescue teams. The project,
which includes discourse between medical first responders and research
institutes, has made it its goal to identify and chart the needs and pave the
13
13
Bar Mitzvah
Bar Mitzvah
Bar Mitzvah
way for additional research in fields such as training
methods, understanding the human toll of disasters
on first-responders, examining the ethical and legal
issues, identifying the personal protective equipment
necessary in chemical and biological events and
utilizing blood and blood products in large-scale
disasters.
Limiting Infections in Hospitals
SONO Project
Israeli partners: Bar-Ilan University; OSM-DAN; Afcon Software Electronics
Prominent partners: Coventry University, UK; Catalonia Polytechnic, Spain
Budget: 12 million Euros
This is a large-scale integrative project which combines medical, financial and
technological matters. The rationale is the prevention, or the reduction, of
hospital-acquired (nosocomial) infections, a financially significant subject in
the European health system. These kinds of infections have many negative
effects, as they neutralize medical treatment, including the most advanced
care, and make hospitalization more expensive due to its extended period
(an average of 8 days for infected patients). The statistical data points to the
fact that 1 of 10 patients is infected with hospital-acquired infections and
that 3 million deaths are caused by hospital-acquired infections.
The project is intended to develop an array of durable antibacterial medical
textiles. We are currently referring to a pilot line, based on a patent-protected
sonochemical process, developed in of Bar-Ilan University's laboratories. The
pilot is intended to create inorganic, antimicrobial nano-particles on medical
textiles such as hospital sheets, lab coats and bandages.
A Robotic Shoe to Prevent Falls Amongst the Elderly
SMILING Project
Israeli partners: Step of Mind; Mishan Center
Prominent partner: The Polytechnic Federal School, Lausanne,
Switzerland
Budget: 3 million Euros
Due to changes in the sensory, neurological and musculoskeletal systems
as a result of aging, healthy elderly people suffer from severe falls which
may limit their mobility. This population groups varies, with almost every
third person aged 65 and older and every second person aged 75 and
older suffers from this problem. The project's goal is to prevent falls and to
improve mobility through a robotic shoe. The project uses chaos theory and
dynamic systems theory to create a shoe to be worn on the individual's feet
and allow for small alterations in steps according to the environment, the
shoe will assist in overcoming the phenomenon and the rehabilitation of the
neurological areas responsible for walking.
Objective Oriented Medication
NANOPORATION Project
Israeli partners: InSightec; CapsuTech
Prominent partner: University of Dundee, UK
Budget: 2 million Euros
The field of drug delivery is one of the hottest in today's world of
pharmaceutics. The medicine is capable of directly reaching the limb
in question, therefore increasing its effectiveness, while minimizing the
damage to the limb's environment. This project, which combines clinical,
industrial and academic expertise, makes use of a number of the most
advanced technologies to create a capsule coating which will deliver active
cancer-fighting medication directly to the malignant tumor. Remote release
of medication through external targeted ultrasound energy and the use of
MRI technologies will enable a heightened absorption of medicine and
intervention in the delivery of medication in the body by imaging.
Bar Mitzvah
Rehabilitation and Purification of Ground-water
AQUAREHAB Project
Israeli partner: Ben-Gurion University of the Negev
Prominent partners: UNESCO; The Flemish Institute for Technological
Research, Belgium; Leuven Catholic University, Belgium; Delft
Technology University, Holland
Budget: 9.25 million
Water treatment is one of the world's central issues today due to the lack
of water in general and the severe lack in potable water in particular. The
project's goal is to develop innovative rehabilitative technologies for soil,
groundwater and surface water, which have been polluted by hazardous
material (Nitrogen compounds, pesticides, chemical compounds). The
technology is meant to be used in seashore areas. Among the innovative
aspects of the project are smart biomass containing carriers for treatment
of water in open trenches; in-situ technologies to restore degraded surface
water by inhibiting influx of pollutants from groundwater to surface water;
multifunctional permeable barriers and injectable Fe-based particles for
rehabilitation of groundwater. One of this project's main results will be
an aquifer management tool which integrates multiples measures with
ecological and economic impact assessments of the whole water system.
A Revolution in Archeological Research
RAIELSP Project - ERC programme
Winning researcher: Professor Israel Finkelstein, Tel Aviv University
Budget: 2.9 million Euros
The study of antique biblical texts, along with research of material
culture, was the pillar of European study since the enlightenment. Today,
conventional research has reached a dead end. Part of the problem stems
from the fact that the biblical testimony was written long after the events
described took place, as well as the fact that the writers and researchers
had a theological agenda. Exact and life sciences research methods are
not limited by the same prejudices and can expose information which isn't
apparent. The innovation in this project lies in action within ten different
research tracks borrowed from the life and exact sciences in order to better
understand ancient Israel, while using advanced methods in the fields of
genetics, mathematics, chemistry and archeozoology.
The Next Cellular Revolution – A User-Centric Paradigm
PERIMETER Project
Israeli partner: Traffix Systems
Prominent partners: Telefonica, Spain; The Technological University,
Berlin, Germany; University of Geneva, Switzerland
Budget: 5.5 Million Euros
Every cellular phone user knows the limits in his relationship with the service
provider. From the moment you sign a contract, you lose control over the
management of your user profile and your actual consumption. If you want,
for example, to use a cheaper service from a competitive service provider, you
are limited with no real mobility available. Personal information isn't properly
guarded and companies often harm users' privacy. The project's main goal is
to create a continuous mobile environment open to cellular users and end
users as to better control cellular service consumption, along with complete
control over one's personal information all the while receiving a combined
personal consumption report. This is a project with significant social-financialconsumer effects. This revolution will require a change in regulations as
well as the need to allow users to be constantly connected, though a highquality connection, to multi-access and multi-operator networks of the
future internet. The project will deal with the development and application of
protocols designed to match requirements such as mobility, privacy, safety,
initialization and transparency and based on experience quality.
13
14
13
Raising Awareness of Nanotechnology amongst Youth
NANOYOU Project
Israeli partner: Ort Israel; Artic Israel – International Management
Services
Prominent partners: Cambridge University, UK
Budget: 1.8 million Euros
Surveys show that most of Europe's citizens do not understand and are
unaware of the Nanotechnology's importance and it's potential. The
project's assumption is that any increase in the public's awareness in this
field will positively contribute to the decision-making process in the future
use of nanotechnology. The focus on 11-25 year olds stems from the need
to beginning influencing the future's communities. The project includes
temporary and permanent exhibitions, innovative computer games,
workshops, experiments and online content whose goal is to promote dialog,
increasing participants' awareness of the ethical, legal and social aspects of
nanotechnology.
Storing Carbon Dioxide
MUSTANG Project
Israeli partners: The Technion; Environmental & Water Resources
Engineering; The Geophysical Institute of Israel; Lapidoth Israel Oil
Prospectors
Prominent partners: Cambridge University, UK; the National Institute
for Scientific Research in France; Uppsala University, Sweden
Budget: 12 million Euros
The global struggle to prevent global warming includes the search for
efficient ways to trap carbon dioxide and its storage. This strategy requires
research to characterize geological formations and the sites destined for
the safe storage of carbon dioxide. The project's objectives are to develop
methodologies and tools to assess and characterize suitable deep saline
aquifers for the storage of carbon dioxide, while providing measures of risk
necessary to prevent environmental damage and ensure public safety. This is
the development of original methods to store carbon dioxide with improved
abilities to determine the relevant physical characteristics of the site and the
short reaction time in inspection and supervision of the process both during
the injection as well as the storage phases.
A Plastic Optic Fiber - Low Cost with High
Transmission Capabilities
POF-PLUS Project
Israeli Partner: Rosetta IP
Prominent partners: France Telecom; Telecom Italy; Eindhoven
University, Holland; Fruanhoffer Institute, Germany
Budget: 4 million Euros
Fiber Optics are central in communication networks in the transfer of large
amounts of data. Regarding alternative solutions, fiber optics have a number
of advantages such as: simplicity in connection, small diameter, low weight
and lack of electromagnetic emissions. The project's aim is to develop a
standard, plastic fiber optic with a high broadcast ability and a low-usage
cost. The fiber developed will allow for transmission services for wireless and
non-wireless for NGN users as well as the deployment of an optical network
from the user's home to large information centers and main network storage
facilities (FTTH).
From Optics to Surgery
MiniSurg Project
Israeli partner: VisionSense
Prominent partner: The Inter-University Centre for Micro-Electronics,
Belgium
Budget: 3.4 million Euros
Advanced medicine makes more and more use of minimally invasive
14
surgery (laproscopic) through
optical equipment, such as
microscopic cameras. Using
this equipment can make the
patient's healing process easier
and
shorten
hospitalization
periods. VisionSense developed
a
patented
breakthrough
technology – a vision sensor
activated and controlled by
surgery software for minimally
invasive surgery. The technology
provides the surgeon with realtime lookout, at a high-resolution,
with stereoscopic vision this kind of vision provides depth perception,
improving surgical abilities, while minimizing the dangers for the patient. The
sensor allows a move from two-dimensional optics to three dimensional
"smart" visions. The project's goal is to create a jump forward on the current
patent – through the developing of an advanced, reduced stereoscopic
sensor which will allow for HD broadcasts at a low cost and with highbroadcasting capabilities.
Neurosurgical Surgeries Using Miniature Robots
ROBOCAST Project
Israeli partners: Mazor Surgical Technologies; The Hebrew University of
Jerusalem; The Technion
Prominent partners: Acrobat Company, UK; The Milan Polytechnic, Italy;
Imperial College, London, UK; Karlsruhe University, Germany
Budget: 4.9 million Euros
No, this isn't science fiction. The project is meant to develop scientific and
technological methods to create miniature robots to assist in Neurosurgical,
mainly susceptible surgeries, such as brain surgery which requires one
to open the skull and demand accuracy. A modular system, allowing a
reduction of the footprint, will be developed with two robots and one
active bio-mimetic probe, able to cooperate among themselves in a biomimetic sensory-motor integrated framework. A gross positioning 3-Axes
robot will support a miniature parallel robot holding the probe to be
introduced through the “Keyhole” opening into the skull of the patient The
aforementioned technology will be the basis for a variety of possible systems
and tools with the aim of guiding the surgeon to the exact location in the
brain and allow for the precise application of the surgical procedure.
The Next Generation of Conference Calls
3DPresence Project
Israeli partner: Radvision Israel
Prominent Partners: Telefonica Spain; Phillips Holland; Fraunhoffer
Institute, Germany
Budget: 5.5 million Euros
The project's role is to develop the next generation of online conference
calls, based on IP's in a three dimensional environment. This will create the
feeling of human presence and a natural impression which will intensify the
team members' execution ability. The existing conference call systems have
failed to overcome technology's "presence" challenge, which presents a
sustainable alternative to business trips (which include costs, lack of comfort,
and a carbon footprint caused by plane fuel). The existing solutions, have
partially dealt with the existing deficiencies, they are expensive to apply and
do not use 3 dimensional images that may allow for far away users to create
eye contact and interactions other than in a very limited fashion. The project
assumes that joint communication with employees, partners, suppliers and
clients spread across the globe, requires a simple, comfortable and user
friendly solution. The project will develop a technological solution allowing
one to hold 3 dimensional high-quality video conferences with a large
number of participants.
15
13
Bar Mitzvah
Bar Mitzvah
Bar Mitzvah
Early Detection of Autism
ASD Screening Project
Reintegration grant for an Israeli researcher returning to Israel:
Dr. Ayelet Ben Sasson, University of Haifa
Grant: 100,000 Euros
Researchers around the world are attempting to decipher disorders from the
Autism Spectrum Diseases through the development of tools for the early
identification of this disorder. This kind of identification is necessary to allow for
early intervention. Studies have shown that there are many cases of Autism,
which can be identified during childhood, but the existing tools have so far only
achieved partial success and therefore cannot be applied. The project's goal,
with the participation of researchers and leading research institutions around
the world, is to examine the forecast period for early diagnosis in children and
the applicability of these diagnosis tools as part of the healthcare framework.
Post-Stroke Rehabilitation of the Nervous System's
Function
PLATICISE Project
Israeli partner: D-Pharm
Prominent partners: Novartis; Glaxo Smith Kline; Zurich University
Switzerland; Cambridge University, UK
Budget: 7.7 million Euros
Nerve degenerative diseases lead to damage of the nervous system's
circuits, due to the loss of connectors, axons and neurons. The loss can be
gradual, such as in Alzheimer's, or quick, like a stroke. After the damage has
been done, the nervous system can partially compensate for the loss of
connectors by the creation of new paths, a process called plasticity. Adults
can acquire renewed function after a stroke and compensate for the loss of
cells from Alzheimer's, for example, but only until it reaches a critical level.
Children, on the other hand, have the ability to compensate for the damage
incurred in the central nervous system at a much higher level in most cases.
The overall concept of the project, is the belief that treatments that enhance
plasticity will become one of key medications that will improve neurological
function in the damaged human nervous system. The purpose of the project
is to bring this moment closer.
Genetic Enhancement of Plants to Increase Yields
RECBREED Project
Israeli partners: Weizmann Institute of Science; O.S.M.-DAN
Prominent partners: Keygene, Karlsruhe University, Germany; National
Institute for Scientific Research, France
Budget: 4 million Euros
The significant shortage of food in the world has lead, in recent years, to a real
crisis. One of the solutions to the problem, directly connected to population
growth and as a derivative of the increased demand for food, is the genetic
enhancement of plants used for agricultural crops. Successful and efficient plant
breeding depends on rapid recombination of advantageous traits to form new
crop varieties. In recent years new breeding techniques have been introduced
which rely on transgenic alteration of somatic cells and regeneration into plants
with novel properties. The objective of the project is to provide plant breeders
with new tools, allowing better control over homologous recombination in
plant cells. The expected outcomes of the project are efficient gene targeting
technologies for precise engineering of plant genomes.
An Innovative Treatment for a Rare Genetic Disease
EUROTRAPS Project
Israeli partner: Pronto Diagnostics
Prominent partner: The National Institute for Health and Medical
Research, France
Budget: 3.8 million Euros
TRAPS (TNF Receptor Associated Syndrome) is a rare disease, caused by a
Bar Mitzvah
mutation in the TNFR1 that leads to renal amyloidosis, which in up to 20%
of cases may be fatal. It is characterized by recurrent bouts of fever and pain
and it is usually associated with patients of European descent. The existing
treatment has not been proven as effective in the control of these bouts and
the prevention of renal amyloidosis. The project has led to the creation of an
interdisciplinary consortium, which combines ideas, resources and datum
from research institutes and business corporations from six countries, with
the aim of gaining insights into the natural course and pathophysiology of
TRAPS, particularly in children. The goal is to identify the disease mutations
and develop new treatment methodologies to ease the symptoms and
therefore improve the welfare of the patients and their families.
Genetics and the Family
From Child to Parent Project – ERC programme
Winning researcher: Dr. Ariel Knafo, The Hebrew University of Jerusalem
Budget: 1.4 million Euros
What affects the social behavior of children – nature or nurture? This
project is the first one to directly address these issues with DNA information
on family members and quality observational data on parent and child
behaviors, following children through early development. Pilot results show
children’s genes predict parenting, and an important task for the study will
be to identify mediators of this effect, such as children s temperament. The
project will lay the ground for further research into the complexity of geneenvironment correlations as children and parents co-develop.
Composite Materials Profiles for the Aerospace Industry
IMac-Pro Project
Israeli partner: Israel Aerospace Industries
Prominent partners: Eurocopter Germany; Dassault France; EADS
Germany; Alenia Italy
Budget: 8.9 million Euros
The project goal is the development of an industrial process which combines
the major airplane manufacturers and material suppliers to create a variety
of robust aeronautic profiles of composite materials. The project will focus
on the cost-effective manufacture of geometrically complex profiles with
changing dimensions and single or multiple curvatures. The technology
developed as part of the project has a significant potential for the efficient
manufacture of aeronautic profiles such as floor beams, structural stiffeners,
frames, spars and truss structures that are lightweight and designed optimally
to withstand operating loads in service.
Advanced Manufacturing Technology for the SemiConductors Industry
MAGIC Project
Israeli partner: KLA-Tencorn
Prominent partners: The Institute of Atomic Energy, France; Fraunhoffer
Institute, Germany; STM Micro Electronics, France; the Microelectronic
Institute, Stuttgart, Germany; FUJIFILM Electronic Materials (Europe),
Belgium
Budget: 20 million Euros
The project is intended to support the development of ML2 technology for
the CMOS manufacturing environment of the semiconductor industry. This
technology develops lithography aimed to overcome the limitations in the
manufacturing of CMOS technologies which make use of optic lithograph
techniques based on lubrication: limiting the complexity level and manufacturing
costs. The project is supported by the largest CMOS manufactures in the world,
including: STMicroelectronics, TSMC, Toshiba and Texas Instruments.
The project runs to develop a basic ML2 platform suitable for 32
nanometers. The platform will include a programme which deal with the
basis of information and which carries out production control. At the end of
the project an ability demonstration for the integration of CMOS processes in
a manufacturing environment on the ML2 platform will be presented.
15
16
13
When Israeli Capabilities
Meet European Capabilities
Joel Tsafrir
Dozens of Israeli companies and academic research organizations
collaborate on a variety of projects with their counterparts in Europe, as
part of the European Framework Programme. We gathered a number
of representatives from these organizations to get their impressions
regarding the benefits they gained from participating in the programme
in terms of knowledge, experience, capital and business ties
Nowadays, when Israel's image is at a low
point, just look at the Goldstone Report, it is
important to point out that there are a number of
actors in Europe, both in industry and academia,
which percieves Israel differently. These are
companies and corporations, research institutes
and universities, constantly in touch with their
Israeli counterparts in the framework of research
and development projects, which are part of
the European Framework Programme that
advances cross-border collaborations in the
field of R&D. Many Israelis testify that the direct
contact with representatives of companies and
academia, which has more than once led to
personal friendships, has changed Israel's image
in European eyes. Those used to seeing Israel
on television screens, as a violent country which
abuses human rights, have suddenly discovered
a liberal, advanced, lively and vibrant society, rich
in knowledge and technology, of which Europe
can derive significant benefits. What began as a
first visit for many has become a series of visits
and tours, intensifying the Israeli-European
relationship.
"I have said more than once, jokingly, that we
should get funding from the Ministry of Foreign
Affairs for our contribution to Israel's image and
Israeli propaganda," says Marcel Shaton, the
General Manager of ISERD, The Israel-Europe
R&D Directorate responsible for the coordination
of Israel's activities vis-à-vis the European
Commission regarding the European Framework
Programme. Shaton, himself a renowned and
respected diplomat, is aware of the benefits
Israel derives from its integration in the European
Framework Programme in all fields, financial and
political as one. There is no doubt that he also
draws encouragement from the Programme's
success, as one of the pioneers that advanced
the integration of Israel into the European R&D
programme, while a number of local voices that
were skeptical at first.
Today, 13 years after Israel joined the
Framework Programme, we can pause and
summarize the benefits Israel has thus far
derived from the Programme in different fields.
For this, and to mark the "Bar Mitzvah" year since
Israel joined the European R&D programme, we
assembled a panel of representatives from a
number of companies that have participated, or
are currently participating, in different projects
within the European Framework Programme for
Research and Development.
Leveraging Knowledge
One of the strong sentiments which arose
during the panel was that participation in the
projects, beyond the financial aspect, allows for
mutual inspiration between Israelis and Europeans,
inspiration that provides concrete added value
and knowledge. "As someone who participated
in a number of projects, I am a strong believer
in the European Framework Programme for
Research and Development", says Avi Gal, R&D
projects & Alliances Director at Gilat Satelite
Networks. Participation in the projects allows
for mutual inter-cultural inspiration, between
representatives from different countries, each
of which comes from a different organizational
culture. You could see how everyone gathers
around one table, Germans, Greeks, Belgians and
Israelis, discussing and exchanging ideas, through
an inclusive and comprehensive view of the big
picture. If throughout the meetings a successful
collaboration is formed, actual inspiration is created
and everyone wins. You can even collaborate with
competitors and continue to compete with them
afterwards, or simultaneously, on the business field.
This combination is particularly applicable when
discussing the development of future technology.
That is the uniqueness of the Framework
Programme and I very much believe in it".
Eyal Neria, CEO of CapsuTech, a young biotech
company which works within the incubator of
Nazareth, discusses the many options available
for small companies, particularly in accessing
the huge medical companies in Europe. "The
project we are occupied with is defined as a
collaboration between academia and industry.
Our involvement enables us to leverage the
knowledge we acumulated. The consortium
includes leading research organizations and
academia and of course top medical researchers.
For example, Dundee University in Scotland
– a leader in cancer research, a field in which
we specialize – the University of Haifa and the
Israeli company InSightec. These also deal with
important strategic issues in the field of medicine
and are at the forefront of medical research, such
as medical simulation, ultrasound or designing the
future operating room, and I have no doubt that
we couldn't have reached them without having
participated in the European R&D programme".
And indeed, the ability of small enterprizes to get
access to large projects involving huge corporations
from Europe is seen as an important advantage of
the European Framework Programme. Gerardo
Nahum, Managing Director of Rosetta IP from
Netanya which works in the field of microchips,
knows all about the integration of a young
company into a large European project in the field
of optical communications. Partners in the project,
whose goal is to lay down a plastic optic cable for
household communication, works to decrease the
costs of available communications. Those huge
corporations in the field of communication, such
as "France Telecom", and "Telecom Italy," along
13
Bar Mitzvah
Bar Mitzvah
Photo: Ziv Sade
Bar Mitzvah
17
Bar Mitzvah
Right to Left: Avi Gal, Eyal Neria, Chaim Rafalowski, Gideon Hazzani, Prof. Oded Maimon, Vered Ariel-Nahari, Gerardo Nahum, Marcel Shaton, Joel Tsafrir, David Tolub
with additional significant players such as research
institutions from Germany, large laboratories
and additional organizations, welcomed the
participation of Rosetta IP. Nahum claims, that
the participation in the project also enabled
the company to raise foreign investment. This
combination between access to laboratories and
equipment at a scope that no small company
could achieve on its own, along with strengthing
the image and rasing capital, seems to Nahum
as proof to the importance of integration into
the European R&D programme for small Israeli
companies.
Both Nahum and Neria agree that participation
in the European Programme is a significant and
powerfull leverage for small and medium sized
enterprizes. In addition, they believe that the
funding for small companies should be increased
as opposed to large companies. In their opinion,
for small and medium sized enterprizes it is
important to integrate into projects with immediate
consequences and not just long term.
Chain Reaction
In addition to business organizations, public
organizations also take part in the Framework
Programme. One of the interesting examples
of cooperation is the integration of the Israeli
Magen David Adom (Israel's first aid services)
into European projects, particularly regarding
the preparation for large-scale disasters. Chaim
Rafalowski, EU Projects & DM Coordinator in
MDA, speaks of their participation in a European
project whose goal was to map out the medical
needs in case of large-scale disasters. "The project
examined the existing technologies and pointed
out the gaps to be bridged, all this with the help of
end users and those in the field from all countries.
In addition, the project had partners from academic
organizations and research institutes and led to a
significant breakthrough related to preparations
for large-scale disasters, through cross-sector
collaborations between the business security sector
and the civilian rescue sector. This was a unique
and particularly interesting experience for us. Up
until two years ago we didn't know anything about
the European R&D programme".
Another important aspect raised by Rafalowski
is the dialogue which developed between
colleagues in Europe. "Very strong networking was
created. Suddenly we realized we weren't the only
ones in the fight against terror. Europe too has its
problems as well as limited resources. Therefore,
the search for new technologies, which provide
answers for joint problems, through an extensive
dialogue between them and the industry is at the
which exhibit this advantage.
Europeans, so it seems, are occupied with the
field of Homeland Security. Gideon Hazzani,
Director of new business technologies in
VERINT, spoke of two central European projects
that the company participated in, as the leading
provider of software-based analytical solutions
for the security and business intelligence markets.
VERINT's solutions transfer voice, video and
text to applicable information – necessary and
informative insight to achieve strategic goals. The
first project is aimed at handling emergencies
and national disasters such as large-scale terror
attacks, accidents in large plants posing threats of
environmental disasters, enormous fires and so
on. The idea is to translate VERINT's abilities from
the field of military intelligence to the civilian world,
"Our ability to understand where the market is going is an
important advantage which stems entirely from our participation
in the European Framework Programme. The ability to know what
is on Europe's technological agenda is very valuable information"
core of the project," highlights Rafalowski.
One of the main advantages pointed out by
Chaim Rafalowski is that participation in one
project led to participation in additional projects.
These are important projects wherein the partners
are organizations which are similar or paralel to
MDA in Europe, such as Madrid's Ambulance
Company, Ambulance Services in Holland and
the Austrian Red Cross. In addition, collaboration
with Al-Quds University in East Jerusalem
was created as part of the European Effort to
encourge an Israeli-Palestinian dialogue. All
panelists agreed and sopke of similar instances
with the aim of enabling decision makers to get a
real-time picture of the event's development so as
to make informed decisions which will reduce the
uncertainty and minimize the number of casulties.
Large-scale disasters lead to feelings of extreme
fear and chaos and therefore the technology's
goal, amongst others, is to minimize the feeling
of panic and to reduce the damage caused to
decision makers due to this. The project combined
many technologies from Israel and Europe and its
budget stood at 9.1 million Euros.
18
13
Another project was related to airports security,
which have become sensitive zones and a target
to terror attacks, in recent years, favored by
extreme terrorist organizations. Here too, Verint
was asked to combine its abilities in the field of
intelligence and video technologies to help secure
airports. No less than 20 different organizations in
Europe partook in this project including end users
and clients, amongst them Heathrow Airport in
London. The project's highlight was the attempt to
mold the concept of European security in general
and particularly in airports as we head closer to the
Olympic Games in London in 2012.
Access to Knowledge
An additional aspect which arose during the
panel was the access to new knowledge in Europe.
David Tolub¸ President & CEO of "OVERSI",
a software company that develops solutions
to reduce overload traffic on communication
networks, claims that thanks to the integration of
Israeli companies into different R&D projects they
are granted access to important new knowledge
that is created through the cooporation with large
corporations from Germany, France, Great Britain
and more. This is the remarkable ability of Israelis
to plug into important sources of knowledge
and enrichment. Later on this knowledge can be
imported to Israel.
Tolub tells, for example, of the involvement
of his company in a European strategic project
which is trying to shape the future of the internet.
The presumption is that over 90% of internet
traffic will be video files and the project deals with
the evaluation of the next generation of video.
OVERSI's technology which deals with the transfer
of information between users without a central
server, by transferring large amounts of information
at high-definition quality, integrated well into
these projects. "Our ability to understand where
the market is going is an important advantage
which stems entirely from our participation in this
European project," highlights OVERSI's General
Manager.
Tolub agrees that the access to large-scale
resources is a clear advantage for Israeli
companies, but also raises another interesting
point. Participation in research projects allows the
managers to allocate manpower for long-term
planning, as well as appropriate financial backing.
"Many managers in Israel deliberate extensively
between what is pressing and what is important,
between caring for customers immediately and
long-term future planning. The integration into
European projects forces the managers to allocate
manpower to the project which is entirely focused
on future developments."
Avi Gal of Gilat also agrees that the ability to
know what is on Europe's technological agenda
is very valuable information which assists Israeli
companies, all of which is in addition to the
benefits found in long-term strategic thinking.
"We, for example, didn't know anything about a
European project that was supposed to ensure
communication accessibility to remote rural
18
Wanted – Intellectual Openness
Differences in organizational culture are a
recurring issue in any discussion concerning
encounters between Israelis and Europeans.
According to Chaim Rafalowski from MDA this
is an unavoidable situation that often leads to
frustration: "The culture differences between
us and Europeans are significant. In Israel the
approach is command-like, stemming from
the IDF, where the commander is the one that
decides. The Europeans, on the other hand,
emphasize consensus and reaching agreements,
even at the cost of slowing things down. The latter
can be very frustrating for Israelis that feel that the
discussion is over and it is time to end it. But those
who want to work outside of Israel must adapt
themselves and experience different thinking
processes. Although it's not easy, it's part of the
projects' charm. It requires us to have intellectual
openness which assists us in additional fields. For
example the need to cooperate with additional
sectors such as the industry."
Eyal Neria on the other hand, sees this as
a successful match, despite the differences
between Israelis and Europeans. "The Israelis
bring with them creative and innovative ideas,
as well as improvisation skills. They are to the
areas. This suits our vision and the fact that we
were exposed to such projects, even if not always
at a senior status, ensured a connection to the
communication strategy in Europe. This is very
valuable knowledge."
Gal shares Tolub's opinion about the
importance of financing for the development
of long term projects. "It is important not only to
small companies, but also for large companies, as
sometimes future development competes against
current developments and the ability to raise
funds for the future definitely influences positive
decision making in that direction."
Change of Orientation
A considerable number of managers that
participated in the panel admitted that the meeting
with the Europeans led to a change in their
attitude towards Europe. Prof. Oded Maimon,
from the Industrial Engineering Department
of Tel Aviv University, who participated in two
projects in the field of nano-technological and
biological engineering, exclaimed that up until
a few years ago the academic orientation was
completely American. "Thanks to the participation
in European projects we changed direction and
now we often work with Europe. We learned
to appreciate the EU's abilities and, one has to
admit, the cultural and geographical proximity.
It is important to remember that Europe offers
Israelis a combination of large R&D centers, huge
corporations, diverse research organizations
and universities all of which are partners in these
various projects. The research partnerships with
Europe lead us to depend less on donations and
more on the integration into research projects.
This is a huge advantage. Beyond this, the funding
point and direct. The Europeans may be more
organized and less interested in short-cuts, but
this match between Israelis and Europeans
actually pushes to innovation and cooperation,
while thinking out of the box."
Avi Gal claims that the Europeans have learned to
respect the Israeli companies and their competitive
status in the world. "For example, we are
considered global leaders in the field of Satellite
Networks, second only to the United States and
leaders in Europe. The Europeans appreciate this
and want to hear what we have to say."
In his opinion, when the collaboration is with a
different organizational culture, the rules also
apply on industry-academia ties, each of which
speaks a different language: "Assembled around
one table are representatives from different
sectors. The academia looks further ahead and at
times that makes it difficult on the industry. But
then it turns out that a dialogue has evolved, as
many researchers are interested in the problems
that arise in the field. The important thing is not to
give up. Everyone comes with their own point of
view and the dialogue leads to mutual inspiration,
by combining the different angles."
we received is much more than we could have
raised on our own. For example, the budget we
received for PhD's participating in the projects is
three times that of other researchers in academia.
A serious and new momentum has been created
here which we lacked beforehand."
To conclude, the panel's participants
emphasized, unanimously, that the main
advantages and benefits, for business and public
organization alike, by participating in the European
projects of the Framework are: an incentive for
innovation, business connections and exposure
to capital and resources at a particularly largescale, alongside access to research centers,
collaboration, and exposure to new markets and
customers. In short, this is a significant platform for
business development, both in the short and long
term.
Investing in Proposal Writing
One of the important subjects in the process of
accepting a company into a European project
is the quality of the proposal submitted. Israelis
tend not to put enough effort in writing the
proposal, Chaim Rafalowski from MDA cautions,
in addition they don't understand the weight
Europeans ascribe to a well written proposal.
In his opinion, "As Israelis we have many
advantages, but we tend to present proposals
that are lacking or forget entire chapters. This
isn't a complicated process, but more than once
a good idea has been rejected due to a poor
proposal. It is important to insist on preparing
the proposal as required and there are very clear
rules that cannot be deviated from. Although
there is no replacement for a successful idea, it
is unfortunate to lose out due to technicalities."
13
Bar Mitzvah
Bar Mitzvah
Bar Mitzvah
Bar Mitzvah
Ten Recommendations
How to Participate in European R&D Projects
1
Participating in the consultative presentation
The presentation explains the program and its goals.
This explanation is imperative to adjust one's expectations.
Start thinking NETWORKING
2
3
One-on-one meeting with ISERD's experts
Identify the relevant issues in the business plan.
Get used to thinking NETWORKING
Take immediate action
Understand the schedule and plan steps in advance.
Build NETWORKING steps
4
5
Attain system support and obtain resources.
Develop NETWORKING capabilities
Collect information
Learn from similar projects and
discussions with participants.
6
Recognize NETWORKING targets
7
Raise support
Act like a European
For the Framework Programme you are considered
an integral part of Europe.
Travel to NETWORKING meetings
Apply to ISERD's support fund
Financial aid to integrate into the Programme.
Invest in NETWORKING
9
8
Awareness of the different kinds
of participation available
Set-up collaborations
Understand the abilities and needs of your
future partners.
Respect your NETWORKING colleagues
Coordinator? Entrepreneur? Partner?
Focus your NETWORKING efforts
10 Join the club
The investment bears fruit in the long term as well.
Reap the rewards of NETWORKING
19
20
13
ISERD's Team
Information and Communication Technologies;
Research Infrastructures
Mr. Aviv Zeevi-Balasiano
Director
Tel: 00-972-3-5118121
[email protected]
Ms. Hadas Daar
Projects Officer
Tel: 00-972-3-5118123
[email protected]
Mr. Felix Cincarevsky
Projects Officer
Tel: 00-972-3-5118167
[email protected]
Nanotechnologies, Materials, Production;
Transport (incl. Aeronautics); Space; Security
Dr. Nili Mandelblit
Director
Tel: 00-972-3-5118120
[email protected]
Health; Food, Agriculture and Biotechnology;
Environment; Energy
Dr. Rami Kalfon
Director
Tel: 00-972-3-5118119
[email protected]
Ms. Adi Yaniv
Projects Officer
Tel: 00-972-3-5118171
[email protected]
Mrs. Lior Ben Artzi – Gershon
Projects Officer
Tel: 00-972-3-5118182
[email protected]
People (Marie Curie); Social Sciences &
Humanities; Science in Society
Mrs. Orly Mulla
Projects Officer
Tel: 00-972-3-5118181
[email protected]
Mrs. Mika Mor
Projects Officer
Tel: 00-972-3-5118191
[email protected]
Ms. Smadar Hirsh
Director
Tel: 00-972-3-5118126
[email protected]
Mr. Alon Rubinstein
Projects Officer
Tel: 00-972-3-5118125
[email protected]
Ms. Noa Gur
Advisor
Tel: 00-972-3-5118190
[email protected]
Mrs. Vered Ariel-Nahari
Advisor, Head of PR
Tel: 00-972-3-5118168
[email protected]
Mrs. Tony Levy
Information & Web Specialist
Tel: 00-972-3-5118180
[email protected]
Mr. Eyal Bashevkin
System Administrator
Tel: 00-972-3-5118176
[email protected]
Management
Mr. Marcel Shaton
General Manager & ERC
Tel: 00-972-3-5118122
[email protected]
ISERD is holding weekly seminars to introduce the seventh framework programme
Call for more details and registration Tel: 03-5118122
ISERD, Beit Hataasiya, 29 hamered St., Tel-Aviv
www.iserd.org.il
Ms. Nitsa Porat
Secretariat
Tel: 00-972-3-5118122
[email protected]